Cross Cancer Institute, 11560 University Avenue

Edmonton, Alberta TG6 1Z2

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC) — Completed